STAT+: Biden administration moves to axe Trump 340B rule targeting community clinics
WASHINGTON — The Biden administration on Tuesday moved to axe a Trump-era policy that would have targeted federal drug discounts for clinics serving the poor.
While several other controversial Trump drug pricing policies on importation, international reference pricing, and drug rebates remain in limbo, this is the second time that HHS Secretary Xavier Becerra has sided with providers at the expense of drugmakers on contentious policy related to the federal 340B drug discount program.
